Literature DB >> 23771702

Carotid intima media thickness and arterial stiffness in children with acute rheumatic fever.

Murat Çiftel1, Osman Yılmaz, Fırat Kardelen, Abdullah Kocabaş.   

Abstract

Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) constitute important public health problems in developing countries. Inflammation is present both in the early and late stages of the diseases. Chronic inflammation is known to be associated with atherosclerosis. We hypothesize that subclinical atherosclerosis and arterial stiffness may increase due to the ongoing inflammation as well as the increased pulse pressure and left-ventricular systolic dysfunction in RHD. The purpose of the present study was to investigate carotid intima media thickness (CIMT) and carotid artery stiffness in patients with ARF. Forty patients in follow-up due to ARF in the age group of 7-16 years (disease duration 1-10 years) and 36 volunteered subjects with similar body mass index were included in the study. The subjects included in the present study were compared regarding M-mode echocardiographic parameters and CIMT as well as carotid arterial strain (CAS), carotid artery distensibility (CAD), beta stiffness index (βSI), and pressure-strain elasticity modulus (Ep) as carotid artery stiffness parameters. CIMT (0.52 ± 0.08 and 0.48 ± 0.07 mm, p = 0.01), βSI (5.29 ± 2.98 and 3.02 ± 1.30, p < 0.001), and Ep (426.53 ± 210.50 and 254.44 ± 104.69 p < 0.001) were increased, whereas CAS (0.11 ± 0.01 and 0.19 ± 0.09, p < 0.001) and CAD (10.27 ± 4.69 and 17.76 ± 14.41, p < 0.001) were decreased in patients with ARF compared with the control group. There was a positive correlation between pulse pressure and βSI (r = 0.25, p = 0.02) and Ep (r = 0.28, p = 0.01) in addition to a correlation between left atrial dilatation and CIMT (r = 0.55 p < 0.001) in patients with ARF. CIMT and carotid artery stiffness were increased in patients with ARF. Patients with ARF may have an increased risk of subclinical atherosclerosis and cardiovascular events.

Entities:  

Mesh:

Year:  2013        PMID: 23771702     DOI: 10.1007/s00246-013-0732-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  32 in total

Review 1.  Rheumatic heart disease.

Authors:  Eloi Marijon; Mariana Mirabel; David S Celermajer; Xavier Jouven
Journal:  Lancet       Date:  2012-03-10       Impact factor: 79.321

Review 2.  The pathogenesis of atherosclerosis: an overview.

Authors:  C J Schwartz; A J Valente; E A Sprague; J L Kelley; R M Nerem
Journal:  Clin Cardiol       Date:  1991-02       Impact factor: 2.882

3.  Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation.

Authors:  Zehra Gölbasi; Ozgül Uçar; Telat Keles; Ahmet Sahin; Kerim Cagli; Ahmet Camsari; Erdem Diker; Sinan Aydogdu
Journal:  Eur J Heart Fail       Date:  2002-10       Impact factor: 15.534

4.  Effect of valvular surgery on antibody to the group A streptococcal carbohydrate.

Authors:  E M Ayoub; A Taranta; T D Bartley
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

5.  Pulse pressure, aortic regurgitation and carotid atherosclerosis: a comparison between hypertensives and normotensives.

Authors:  T-C Su; K-L Chien; J-S Jeng; C-J Chang; H-C Hsu; M-F Chen; F-C Sung; Y-T Lee
Journal:  Int J Clin Pract       Date:  2006-02       Impact factor: 2.503

6.  Carotid-wall intima-media thickness and cardiovascular events.

Authors:  Joseph F Polak; Michael J Pencina; Karol M Pencina; Christopher J O'Donnell; Philip A Wolf; Ralph B D'Agostino
Journal:  N Engl J Med       Date:  2011-07-21       Impact factor: 91.245

7.  Rheumatic fever and rheumatic heart disease.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2004

8.  Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association.

Authors: 
Journal:  JAMA       Date:  1992-10-21       Impact factor: 56.272

9.  C-reactive protein and aortic stiffness and wave reflection in middle-aged and elderly men from the community.

Authors:  H R Nakhai-Pour; D E Grobbee; M L Bots; M Muller; Y T van der Schouw
Journal:  J Hum Hypertens       Date:  2007-06-28       Impact factor: 3.012

10.  Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease.

Authors:  N Kütükçüler; N Narin
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

View more
  5 in total

1.  Evaluation of carotid intima-media thickness and carotid arterial stiffness in children with adenotonsillar hypertrophy.

Authors:  Murat Çiftel; Berrin Demir; Günay Kozan; Osman Yılmaz; Hasan Kahveci; Ömer Kılıç
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

2.  İnvestigation of endothelial dysfunction in children with acute rheumatic fever.

Authors:  Murat Çiftel; Osman Yilmaz
Journal:  Ann Pediatr Cardiol       Date:  2020-06-23

3.  Carotid stiffness, intima-media thickness and aortic augmentation index among adults with SARS-CoV-2.

Authors:  Rachel E Szeghy; Valesha M Province; Nina L Stute; Marc A Augenreich; Laurel K Koontz; Jonathon L Stickford; Abigail S L Stickford; Stephen M Ratchford
Journal:  Exp Physiol       Date:  2021-05-14       Impact factor: 2.858

4.  Six-month longitudinal tracking of arterial stiffness and blood pressure in young adults following SARS-CoV-2 infection.

Authors:  Rachel E Szeghy; Nina L Stute; Valesha M Province; Marc A Augenreich; Jonathon L Stickford; Abigail S L Stickford; Stephen M Ratchford
Journal:  J Appl Physiol (1985)       Date:  2022-04-19

5.  Role of Natural Autoantibodies in Ugandans With Rheumatic Heart Disease and HIV.

Authors:  Daniel M Huck; Emmy Okello; Grace Mirembe; Isaac Ssinabulya; David A Zidar; Gregg J Silverman; Lelise Getu; Amy S Nowacki; Leonard H Calabrese; Robert A Salata; Chris T Longenecker
Journal:  EBioMedicine       Date:  2016-02-06       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.